2014年至2020年间西班牙免疫性血小板缺血的流行病学,治疗模式和成本分析:基于人口的研究
Tomás J González-López1, Gabriela Alperovich2, Elena Burillo2
1Department of Haematology, Hospital Universitario de Burgos, Burgos, Spain.
概括
这项研究详细介绍了西班牙的免疫血小板缺血症 (ITP),揭示了其患病率,治疗模式和显著的医疗费用. 它强调了未得到满足的患者需求和ITP的经济负担,包括丢失的工作日.
科学领域:
- 血液学 血液学 血液学
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- 免疫性血小板缺血 (ITP) 是一种以低血小板计数为特征的疾病,导致出血,疲劳和生活质量下降.
- 了解ITP的流行病学,临床特征和经济影响对于患者护理和资源分配至关重要.
研究的目的:
- 提供西班牙ITP人口的全面概述.
- 分析流行病学,治疗趋势,医疗资源利用率和2014年至2020年期间的相关成本.
主要方法:
- 这是一项利用BIG-PAC®数据库进行的观察性,回顾性,基于人口的研究.
- 包括2014年至2020年被诊断患有初级ITP的西班牙儿科和成人患者.
- 对流行病学数据,临床特征,治疗模式,医疗资源使用和成本的分析.
主要成果:
- 估计每10万人口中ITP的患病率为10.8,慢性ITP (cITP) 为每10万人口中2.8.
- 疲劳和表是常见的;慢性患者的血小板数量较低,需要更多的输血.
- 平均每年医疗费用为ITP患者10,741欧元,cITP患者19,809欧元,成年人经历了大量的病假.
结论:
- 这项研究提供了第一个关于西班牙ITP人口状况的全面视图.
- 它确定了未满足的患者需求,并量化了直接/间接成本和资源使用,强调了ITP的重大负担.
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482